We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance to Develop Rapid Ischemia Test

By HospiMedica staff writers
Posted on 25 Sep 2000
A rapid point-of-care diagnostic test for ischemia is being codeveloped by Response Biomedical Crop. More...
(Vancouver, Canada) and Ischemia Technologies Inc. (Denver, CO, USA). The test will be based on proprietary antibodies developed by Ischemia and will be designed to be used on Response Biomedical's Ramp test platform.

The two companies believe a rapid blood test to detect ischemia will provide a valuable tool that will aid doctors in diagnosing and treating patients with chest pain. The test can help them rule out heart attack and reduce the time a patient remains hospitalized. Moreover, it can help doctors identify ischemic patients before they progress to a heart attack, when treatment can prevent loss of heart muscle. The test would be used along with one or more cardiac markers for patients with chest pain.

This test, exclusive to Ramp in a point-of-care format, will further differentiate us from the competition, adding yet another assay to the developing menu of Ramp tests and demonstrating the versatility of the Ramp platform technology, said Humberto Reyes, chairman of Response Biomedical.

Response Biomedical has three Ramp tests for heart attack under development: troponin I, CK-MB, and myoglobin.

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.